scholarly journals Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer’s Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial

2017 ◽  
Vol 56 (1) ◽  
pp. 129-143 ◽  
Author(s):  
Mercè Boada ◽  
Fernando Anaya ◽  
Pilar Ortiz ◽  
Javier Olazarán ◽  
Joshua R. Shua-Haim ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document